Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

DaVita (DVA)

NYSE Health Care Health Care Services S&P 500
$191.35
-3.47 (-1.78%)
Close of Nov 06, 2026 · end-of-day data
Source: DaVita's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$10.71B$10.88B$11.40B$11.39B$11.55B$11.62B$11.61B$12.14B$12.82B$13.64B
Operating income$2.03B$1.81B$1.53B$1.64B$1.69B$1.80B$1.34B$1.60B$2.09B$2.04B
Interest expense$394.01M$406.34M$461.90M$419.64M$282.93M$267.05M$339.25M$373.95M$435.20M$539.92M
Pre-tax income$1.62B$1.40B$1.05B$1.20B$1.32B$1.52B$966.28M$1.18B$1.53B$1.35B
Income tax$431.76M$323.86M$258.40M$279.63M$313.93M$306.73M$198.09M$220.12M$279.66M$293.11M
Net income$879.87M$663.62M$159.39M$810.98M$773.64M$978.45M$560.40M$691.53M$936.34M$746.80M
EBITDA$2.52B$2.36B$2.10B$2.24B$2.31B$2.47B$2.06B$2.34B$2.81B$2.75B
EPS (basic)$4.36$3.52$0.93$5.29$6.46$9.30$6.03$7.62$11.02$10.06
EPS (diluted)$4.29$3.47$0.92$5.27$6.31$8.90$5.85$7.42$10.73$9.84
Diluted shares204.90M191.35M172.37M153.81M122.62M109.95M95.83M93.18M87.27M75.89M
Operating margin19.0%16.7%13.4%14.4%14.7%15.5%11.5%13.2%16.3%15.0%
Net margin8.2%6.1%1.4%7.1%6.7%8.4%4.8%5.7%7.3%5.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$674.78M$508.23M$323.04M$1.10B$324.96M$461.90M$244.09M$380.06M$794.93M$676.44M
Short-term investments$306.98M$32.83M$2.94M$11.57M$20.10M$22.31M$77.69M$11.61M$51.06M$24.30M
Receivables$1.50B$1.71B$1.86B$1.80B$1.82B$1.96B$2.13B$1.99B$2.15B$2.41B
Inventory$160.42M$181.80M$107.38M$97.95M$111.62M$107.43M$109.12M$143.10M$134.56M$160.63M
Total current assets$3.99B$8.77B$8.42B$3.69B$3.15B$3.17B$3.16B$3.14B$3.75B$4.06B
Goodwill$6.02B$6.61B$6.84B$6.79B$6.92B$7.05B$7.08B$7.11B$7.38B$7.55B
Total assets$18.76B$18.97B$19.11B$17.31B$16.99B$17.12B$16.93B$16.89B$17.29B$17.48B
Total current liabilities$2.71B$3.07B$4.89B$2.37B$2.48B$2.40B$2.62B$2.64B$2.97B$3.14B
Short-term debt$160.26M$178.21M$1.93B$130.71M$168.54M$179.03M$231.40M$123.30M$270.87M$109.20M
Long-term debt$8.94B$9.16B$8.17B$7.98B$7.92B$8.73B$8.69B$8.27B$9.18B$10.16B
Total debt$9.10B$9.34B$10.10B$8.11B$8.09B$8.91B$8.92B$8.39B$9.45B$10.27B
Total liabilities$12.93B$13.08B$14.08B$13.81B$14.09B$14.75B$14.70B$14.15B$15.19B$16.32B
Shareholders' equity$4.65B$4.69B$3.70B$2.13B$1.38B$755.51M$712.33M$1.06B$121.12M-$651.08M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.97B$1.91B$1.77B$2.07B$1.98B$1.93B$1.56B$2.06B$2.02B$1.89B
Capital expenditures$829.10M$905.25M$987.14M$766.55M$674.54M$641.47M$603.43M$567.99M$555.44M$575.86M
Free cash flow$1.14B$1.01B$784.50M$1.31B$1.30B$1.29B$961.14M$1.49B$1.47B$1.31B
Investing cash flow-$1.20B-$1.36B-$1.01B$3.00B-$825.37M-$784.73M-$630.35M-$771.80M-$771.43M-$654.95M
Financing cash flow-$1.35B-$766.26M-$625.35M-$4.70B-$1.85B-$1.08B-$1.12B-$1.17B-$816.94M-$1.37B
Dividends paid——$0$0$0$0$0$0$0$0
Share buybacks$1.10B$802.95M$1.16B$2.38B$1.46B$1.54B$802.23M$272.22M$1.39B$1.31B
Stock-based compensation$38.34M$35.09M$73.06M$67.85M$91.46M$102.21M$95.43M$112.38M$102.79M$139.95M
Depreciation & amortization$494.94M$544.13M$574.80M$600.90M$616.63M$667.75M$721.13M$736.47M$716.40M$708.25M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.